Does the Source of Mesenchymal Stem Cell Have an Effect in the Management of Osteoarthritis of the Knee? Meta-Analysis of Randomized Controlled Trials

Overview

Journal Cartilage

Date 2020 Aug 26

PMID 32840122

Citations 37

Authors

Madhan Jeyaraman

Sathish Muthu

Parvez Ahmad Ganie

Affiliations

Soon will be listed here.

Abstract

Study Design: Meta-analysis.

Objectives: To compare the efficacy and safety of bone marrow(BM)-derived mesenchymal stem cell(MSCs) and adipose-derived(AD) MSCs in the management of osteoarthritis of knee from randomized controlled trials(RCTs) available in the literature.

Materials And Methods: We conducted electronic database searche from PubMed, Embase, and Cochrane Library till May 2020 for RCTs analyzing the efficacy and safety of MSCs in management of osteoarthritis of knee. Visual Analog Score(VAS) for Pain, Western Ontario McMaster Universities Osteoarthritis Index(WOMAC), Lysholm Knee Scale(Lysholm), Whole-Organ Magnetic Resonance Imaging Score(WORMS), Knee Osteoarthritis Outcome Score(KOOS), and adverse events were the outcomes analyzed. Analysis was performed in R platform using OpenMeta[Analyst] software.

Results: Nineteen studies involving 811 patients were included for analysis. None of the studies compared the source of MSCs for osteoarthritis of knee and results were obtained by pooled data analysis of both sources. At 6 months, AD-MSCs showed significantly better VAS(<0.001,=0.069) and WOMAC(=0.134,=0.441) improvement than BM-MSCs, respectively, compared to controls. At 1 year, AD-MSCs outperformed BM-MSCs compared to their control in measures like WOMAC(=0.007,=0.150), KOOS(<0.001;=0.658), and WORMS(<0.001,=0.041), respectively. Similarly at 24 months, AD-MSCs showed significantly better Lysholm score(=0.037) than BM-MSCs(=0.807) although VAS improvement was better with BM-MSCs at 24 months(<0.001). There were no significant adverse events with either of the MSCs compared to their controls.

Conclusion: Our analysis establishes the efficacy, safety, and superiority of AD-MSC transplantation, compared to BM-MSC, in the management of osteoarthritis of knee from available literature. Further RCTs are needed to evaluate them together with standardized doses.

Citing Articles

Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.

Cao M, Ou Z, Sheng R, Wang Q, Chen X, Zhang C Stem Cell Res Ther. 2025; 16(1):122.

PMID: 40055739 PMC: 11887158. DOI: 10.1186/s13287-025-04252-2.

Intra-Articular Injection of Human Bone Marrow-Derived Mesenchymal Stem Cells in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Trial.

Lee B, Lee J, Jung J, Ju J Cell Transplant. 2025; 34:9636897241303275.

PMID: 39874108 PMC: 11775978. DOI: 10.1177/09636897241303275.

Anti-necroptotic effects of human Wharton's jelly-derived mesenchymal stem cells in skeletal muscle cell death model via secretion of GRO-α.

Park S, Kwon S, Kim S, Jeong J, Kim M, Choi S PLoS One. 2024; 19(12):e0313693.

PMID: 39621655 PMC: 11611217. DOI: 10.1371/journal.pone.0313693.

Mesenchymal Stem Cells and Their Extracellular Vesicles Are a Promising Alternative to Antibiotics for Treating Sepsis.

Jiang Y, Song Y, Zeng Q, Jiang B Bioengineering (Basel). 2024; 11(11).

PMID: 39593820 PMC: 11591657. DOI: 10.3390/bioengineering11111160.

Evidence-based orthobiologic practice: Current evidence review and future directions.

Jeyaraman M, Jeyaraman N, Ramasubramanian S, Balaji S, Muthu S World J Orthop. 2024; 15(10):908-917.

PMID: 39473516 PMC: 11514545. DOI: 10.5312/wjo.v15.i10.908.

References

Futami I, Ishijima M, Kaneko H, Tsuji K, Ichikawa-Tomikawa N, Sadatsuki R . Isolation and characterization of multipotential mesenchymal cells from the mouse synovium. PLoS One. 2012; 7(9):e45517. PMC: 3445493. DOI: 10.1371/journal.pone.0045517. View

Shapiro S, Kazmerchak S, Heckman M, Zubair A, OConnor M . A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis. Am J Sports Med. 2016; 45(1):82-90. DOI: 10.1177/0363546516662455. View

Vangsness Jr C, Farr 2nd J, Boyd J, Dellaero D, Mills C, LeRoux-Williams M . Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014; 96(2):90-8. DOI: 10.2106/JBJS.M.00058. View

Wolfstadt J, Cole B, Ogilvie-Harris D, Viswanathan S, Chahal J . Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis. Sports Health. 2015; 7(1):38-44. PMC: 4272690. DOI: 10.1177/1941738114529727. View

Shah K, Zhao A, Sumer H . New Approaches to Treat Osteoarthritis with Mesenchymal Stem Cells. Stem Cells Int. 2018; 2018:5373294. PMC: 6165608. DOI: 10.1155/2018/5373294. View

Hass R, Kasper C, Bohm S, Jacobs R . Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011; 9:12. PMC: 3117820. DOI: 10.1186/1478-811X-9-12. View

Bastos R, Mathias M, Andrade R, Amaral R, Schott V, Balduino A . Intra-articular injection of culture-expanded mesenchymal stem cells with or without addition of platelet-rich plasma is effective in decreasing pain and symptoms in knee osteoarthritis: a controlled, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc. 2019; 28(6):1989-1999. DOI: 10.1007/s00167-019-05732-8. View

Kim G, Seo M, Park W, Lee G . Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis. Int J Mol Sci. 2020; 21(9). PMC: 7247342. DOI: 10.3390/ijms21093224. View

Emadedin M, Labibzadeh N, Ghorbani Liastani M, Karimi A, Jaroughi N, Bolurieh T . Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018; 20(10):1238-1246. DOI: 10.1016/j.jcyt.2018.08.005. View

10.

Bora P, Majumdar A . Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017; 8(1):145. PMC: 5472998. DOI: 10.1186/s13287-017-0598-y. View

11.

Sibille K, Chen H, Bartley E, Riley 3rd J, Glover T, King C . Accelerated aging in adults with knee osteoarthritis pain: consideration for frequency, intensity, time, and total pain sites. Pain Rep. 2018; 2(3):e591. PMC: 5741297. DOI: 10.1097/PR9.0000000000000591. View

12.

Tran T, Wu C, Dubey N, Deng Y, Su C, Pham T . Time- and Kellgren⁻Lawrence Grade-Dependent Changes in Intra-Articularly Transplanted Stromal Vascular Fraction in Osteoarthritic Patients. Cells. 2019; 8(4). PMC: 6523621. DOI: 10.3390/cells8040308. View

13.

Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M . Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002; 10(3):199-206. DOI: 10.1053/joca.2001.0504. View

14.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

15.

Kuah D, Sivell S, Longworth T, JAMES K, Guermazi A, Cicuttini F . Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study. J Transl Med. 2018; 16(1):49. PMC: 5840781. DOI: 10.1186/s12967-018-1420-z. View

16.

Kim H, Im G . Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. J Orthop Res. 2008; 27(5):612-9. DOI: 10.1002/jor.20766. View

17.

Huang R, Li W, Zhao Y, Yang F, Xu M . Clinical efficacy and safety of stem cell therapy for knee osteoarthritis: A meta-analysis. Medicine (Baltimore). 2020; 99(11):e19434. PMC: 7220405. DOI: 10.1097/MD.0000000000019434. View

18.

Takemitsu H, Zhao D, Yamamoto I, Harada Y, Michishita M, Arai T . Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells. BMC Vet Res. 2012; 8:150. PMC: 3442961. DOI: 10.1186/1746-6148-8-150. View

19.

Cui G, Wang Y, Li C, Shi C, Wang W . Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: A meta-analysis. Exp Ther Med. 2016; 12(5):3390-3400. PMC: 5103824. DOI: 10.3892/etm.2016.3791. View

20.

Chahla J, Mannava S, Cinque M, Geeslin A, Codina D, LaPrade R . Bone Marrow Aspirate Concentrate Harvesting and Processing Technique. Arthrosc Tech. 2017; 6(2):e441-e445. PMC: 5443590. DOI: 10.1016/j.eats.2016.10.024. View